Overview

Update
Investments
38 Investments in 24 Companies
Exits
6 IPOs & 7 Acquisitions
Founders:
,
Headquarters:
Stamford, CT
Description:
Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in
Website:
http://www.tm-partners.com
Social:

Investor Details

Update
Founded:
2003
Type:
Venture Capital that does Early Stage Venture and Later Stage Venture Investments
Sectors:
Biotechnology, Health Care, Medical Devices
Regions:
United States,

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies.

The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors as well as in other areas utilizing medical technology innovation. Companies developing therapeutic products for life threatening or costly, chronic conditions are of particular interest.

Thomas, McNerney & Partners invests in companies at all stages of their development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. The partnership also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies as well as recapitalizations.

DateInvested InRoundPartner(s)
Jul, 2016$25M / Series E
Oct, 2014$120M / Series F
Jan, 2014$20M / Series E
Jan, 2013$3.6M / Series D
Nov, 2012$25M / Series D
Oct, 2012$30.9M / Series C
Sep, 2012$30M / Series D
Apr, 2012$10M / Series B (Lead)
Jan, 2012$17M / Series B (Lead)
Dec, 2011$15M / Series A (Lead) and
Jun, 2011$15M / Venture (Lead) and
Oct, 2010$15M / Series D
Oct, 2010$12M / Series C
Sep, 2010$20M / Series D (Lead)
Sep, 2010$16M / Venture
Jul, 2010$15M / Venture
May, 2010$43M / Series B
Feb, 2010$17M / Series B
Jan, 2010$64M / Series D
Nov, 2009$30M / Series A
Oct, 2009$17.4M / Series B
Nov, 2007$8M / Series C and
Nov, 2007$20M / Venture (Lead)
Aug, 2007$20M / Series C
Dec, 2006$4M / Series A (Lead)
Dec, 2006$52M / Venture (Lead)
Nov, 2006$13.6M / Series A
Nov, 2006$85M / Series B
Aug, 2006$20M / Series C
Aug, 2006$60M / Series A
Mar, 2006undisclosed amount / Series B (Lead) and
Jul, 2005$8M / Venture
Jun, 2005$10M / Series B (Lead)
May, 2005undisclosed amount / Series A (Lead)
Feb, 2004$2.5M / Series A (Lead)
Jan, 2004$5M / Series B
Oct, 2003$9.2M / Venture (Lead)
Aug, 2003$30M / Venture (Lead)

Current Team (8)

Update

Offices/Locations (3)

Update
  • Office

    60 South 6th Street

    Suite 3620

    Minneapolis, MN 55402

    USA

  • HQ

    One Landmark Square

    Suite 1920

    Stamford, CT 06901

    USA

  • Office

    3366 N. Torrey Pines Court

    Suite 220

    La Jolla, CA 92037

    USA

Add Board Members and Advisors

Add Funds

Add News

Add Competitors

Add Memberships

Add Images

Add Videos